Inventor · disambiguated record
Karen Ebsworth
Also filed as: EBSWORTH KAREN
4 granted patents·2 pending applications·18 citations·filing 2015–2022
71Inventor score
Files withCHEMOCENTRYX INC6
Top patents by PatentIndex Score
6 records- 0191US10532051B2Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-α4β7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2015·Granted Jan 14, 2020·6 cites·7 claims
- 0290US11304952B2Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitorCHEMOCENTRYX INC·Filed 2018·Granted Apr 19, 2022·11 cites·16 claims
- 0375US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 0472US2021322410A1Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alpha4beta7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 0571US11684606B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 0666US2023023075A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karen Ebsworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →